Takara Bio USA Unveils Enhanced Spatial Biology Solutions, Expands Global Reach
Takara Bio USA has unveiled an upgraded, comprehensive bioinformatics software solution to cater to its growing pipeline of applications. The company has also relocated all manufacturing of its Trekker and Seeker spatial biology solutions to its parent company's facilities to cope with increasing global demand.
The enhanced Trekker kits now provide an end-to-end spatial biology solution, integrating spatial omics with epigenetics and immune profiling. This expansion allows the kits to be compatible with formalin-fixed paraffin-embedded (FFPE) samples, making spatial single-cell analysis more accessible to a broader range of researchers using commonly used archival sample types.
The company's president and CEO, Carol Lou, expressed that Takara Bio USA is at the forefront of revolutionizing single-cell spatial biology for de novo discovery. The RetroNectin reagent, used in over 68 gene therapy clinical study protocols worldwide, is a testament to the company's impact on the field. The reagent has been employed by various research institutions and clinical centers, although specific names are not publicly listed.
The Trekker kits have been further enhanced to work with additional research workflows and third-party instrument systems, including those from 10x Genomics, BD Biosciences, Illumina, and Parse Biosciences. This compatibility aims to make the kits more versatile and user-friendly.
Takara Bio USA will showcase its latest offerings at the American Society of Human Genetics (ASHG) Annual Meeting in Boston, October 14-18. The company's strategic expansions and upgrades, including the enhanced Trekker kits and end-to-end bioinformatics software solution, aim to make spatial single-cell analysis more accessible and versatile for researchers worldwide.
